2. PI3K/Akt/mTOR Stem Cell/Wnt
  3. GSK-3
  4. GSK-3β inhibitor 7

GSK-3β inhibitor 7 is a GSK-3β inhibitor with an IC50 value of 5.25 μM. GSK-3β inhibitor 7 is inserted into the ATP-binding binding pocket of GSK-3β and forms hydrogen-bond. GSK-3β inhibitor 7 shows high hepatocyte glucose uptake (83.5%), and can be used in the research of numerous diseases like diabetes, inflammation, cancer, Alzheimer's disease, and bipolar disorder.

For research use only. We do not sell to patients.

GSK-3β inhibitor 7 Chemical Structure

GSK-3β inhibitor 7 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

GSK-3β inhibitor 7 Related Antibodies

Top Publications Citing Use of Products

View All GSK-3 Isoform Specific Products:

View All Isoforms

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

GSK-3β inhibitor 7 is a GSK-3β inhibitor with an IC50 value of 5.25 μM. GSK-3β inhibitor 7 is inserted into the ATP-binding binding pocket of GSK-3β and forms hydrogen-bond. GSK-3β inhibitor 7 shows high hepatocyte glucose uptake (83.5%), and can be used in the research of numerous diseases like diabetes, inflammation, cancer, Alzheimer's disease, and bipolar disorder[1].

IC50 & Target[1]

GSK-3β

5.25 μM (IC50)

In Vitro

GSK-3β inhibitor 7 (Compound 6x, 5 μΜ, 3 h) shows high glucose uptake (83.5%) in musle L6 cells[1].
GSK-3β inhibitor 7 (0-30 μΜ, 30 min) inhibits GSK-3β with an IC50 value of 5.25 μM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

GSK-3β inhibitor 7 Related Antibodies
In Vivo

GSK-3β inhibitor 7 (Compound 6x, oral administration, 20 mg/kg) shows favorable drug-like properties (t1/2: 5.4 h, Cmax: 507 ng/mL) and oral bioavailability in rats[1].
GSK-3β inhibitor 7 (intragastric administration, 1 g/kg) displays no acute toxicity at a 1 g/kg dose in mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley rats (pharmacokinetic assay)[1]
Dosage: 2 mg/kg, 20 mg/kg
Administration: Intravenous injection (2 mg/kg), oral administration (20 mg/kg)
Result: Pharmacokinetic profile of GSK-3β inhibitor 7 (Compound 6x).
Compound Route Dose (mg/kg) t1/2 (h) Tmax (h) Cmax (ng/mL) AUC0-t (hr•ng/mL) AUC0-∞ (hr•ng/mL) CL (mL/hr/kg) F (%)
GSK-3β inhibitor 7 Oral administration 20 5.40 1.67 507 4265 4501 4536 47.4
GSK-3β inhibitor 7 Intravenous injection 2 8.95 0.08 519 859 948.6 2138.66
F: oral bioavailability.
Animal Model: Male and female mice (acute assay)[1]
Dosage: 1 g/kg
Administration: intragastric administration
Result: Increased body weights, caused no death or obvious weight loss.
Showed no marked pathological damage in important organs (brain, heart, liver, spleen, lung, and kidney).
Molecular Weight

547.47

Formula

C27H23BrN4O2S
SMILES

CC1=CC=C(C=C1)S(=O)(N2C=C(C3=CC(Br)=CC=C32)C4=NC(NC5=C(C=CC=C5C)C)=NC=C4)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

GSK-3β inhibitor 7 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

GSK-3β inhibitor 7GSK-3Glycogen synthase kinase-3Glycogen synthase kinase 3DiabetesinflammationcancerAlzheimer's diseasebipolar disorderglucoseHepG2Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
GSK-3β inhibitor 7
Cat. No.:
HY-143261
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.